Otlertuzumab (TRU-016) is a humanized monoclonal antibody targeting CD37, designed for use in cancer research. This antibody selectively binds to the CD37 antigen, a protein predominantly expressed on the surface of B cells, making it a valuable tool for studying B-cell malignancies. Otlertuzumab is utilized in various experimental settings to investigate its potential as a therapeutic agent in treating hematological cancers.
Otlertuzumab (TRU-016) is a humanized monoclonal antibody targeting CD37, designed for use in cancer research. This antibody selectively binds to the CD37 antigen, a protein predominantly expressed on the surface of B cells, making it a valuable tool for studying B-cell malignancies. Otlertuzumab is utilized in various experimental settings to investigate its potential as a therapeutic agent in treating hematological cancers.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
